Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.

Ferket BS, van Kempen BJ, Heeringa J, Spronk S, Fleischmann KE, Nijhuis RL, Hofman A, Steyerberg EW, Hunink MG.

PLoS Med. 2012;9(12):e1001361. doi: 10.1371/journal.pmed.1001361. Epub 2012 Dec 27.

2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

3.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
4.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
5.
6.
7.

Statin utilisation patterns in older Australians living in residential care: 1-year prevalence study.

Gnjidic D, Wilson N, March L, Cumming RG, Cameron ID, Hilmer SN.

Intern Med J. 2015 Jan;45(1):106-9. doi: 10.1111/imj.12633. Review.

PMID:
25582939
8.

Lifetime risk: does it help to decide who gets statins and when?

Jackson R.

Curr Opin Lipidol. 2014 Aug;25(4):247-53. doi: 10.1097/MOL.0000000000000089. Review.

PMID:
24977980
9.

The new Sheffield risk and benefit tables for the elderly.

Weatherley ND, Jackson PR.

QJM. 2011 Jan;104(1):3-12. doi: 10.1093/qjmed/hcq167. Epub 2010 Sep 17. Review.

PMID:
20851821
10.

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.

De Vera MA, Bhole V, Burns LC, Lacaille D.

Br J Clin Pharmacol. 2014 Oct;78(4):684-98. Review.

11.

Shared Risk Factors in Cardiovascular Disease and Cancer.

Koene RJ, Prizment AE, Blaes A, Konety SH.

Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406. Review.

12.

Investigation on cardiovascular risk prediction using physiological parameters.

Lin WH, Zhang H, Zhang YT.

Comput Math Methods Med. 2013;2013:272691. doi: 10.1155/2013/272691. Epub 2013 Dec 31. Review.

13.

[Cardiovascular pathology related to aging. Role of prevention].

Chatellier G, Lang T.

Presse Med. 1992 Jul 22;21(26):1250-5. Review. French.

PMID:
1409481
14.

Secondary prevention of cardiovascular disease in older adults.

Rich MW.

Prog Cardiovasc Dis. 2014 Sep-Oct;57(2):168-75. doi: 10.1016/j.pcad.2014.03.006. Epub 2014 Mar 12. Review.

PMID:
25216616
15.

Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine Tools.

Björnson E, Borén J, Mardinoglu A.

Front Physiol. 2016 Jan 26;7:2. doi: 10.3389/fphys.2016.00002. eCollection 2016 Jan 26. Review.

16.

Model for Predicting Cardiovascular Disease: Insights from a Korean Cardiovascular Risk Model.

Park GM, Kim YH.

Pulse (Basel). 2015 Sep;3(2):153-7. doi: 10.1159/000438683. Epub 2015 Aug 26. Review.

17.

Life Expectancy Calculators [Internet].

Rector T, Taylor B, Sultan S, Shaukat A, Adabag S, Nelson D, Capecchi T, MacDonald R, Greer N, Wilt T.

Washington (DC): Department of Veterans Affairs (US); 2016 Jun.

Supplemental Content

Support Center